Transpek Industry Intrinsic Value
TRANSPEK Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹1085.76 | ₹868.61 - ₹1302.91 | -13.2% | EPS: ₹90.48, Sector P/E: 12x |
| Book Value Method | asset | ₹1241.67 | ₹1117.50 - ₹1365.84 | -0.7% | Book Value/Share: ₹1241.67, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹880.00 | ₹792.00 - ₹968.00 | -29.6% | Revenue/Share: ₹1100.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1188.42 | ₹1069.58 - ₹1307.26 | -5.0% | EBITDA: ₹128.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹3056.25 | ₹2445.00 - ₹3667.50 | +144.4% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹579.07 | ₹521.16 - ₹636.98 | -53.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹745.56 | ₹671.00 - ₹820.12 | -40.4% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹866.67 | ₹780.00 - ₹953.34 | -30.7% | ROE: 7.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹1589.90 | ₹1430.91 - ₹1748.89 | +27.1% | EPS: ₹90.48, BVPS: ₹1241.67 |
Want to compare with current market value? Check TRANSPEK share price latest .
Valuation Comparison Chart
TRANSPEK Intrinsic Value Analysis
What is the intrinsic value of TRANSPEK?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Transpek Industry (TRANSPEK) is ₹1085.76 (median value). With the current market price of ₹1250.75, this represents a -13.2% variance from our estimated fair value.
The valuation range spans from ₹579.07 to ₹3056.25, indicating ₹579.07 - ₹3056.25.
Is TRANSPEK undervalued or overvalued?
Based on our multi-method analysis, Transpek Industry (TRANSPEK) appears to be trading above median value by approximately 13.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 2.25 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.34 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 7.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.66x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Transpek Industry
Additional stock information and data for TRANSPEK
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹135 Cr | ₹120 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹98 Cr | ₹82 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹111 Cr | ₹105 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹47 Cr | ₹12 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹35 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |